International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2024   Volume 14   Issue 1

Adverse Reactions to Fluoroquinolones – Focus on Tendinopathy, QT Prolongation, and Neuropathy: A Review
Download PDF


, , ,
  1. Department of Pharmacology, College of Medicine, University of Jagiellonian, Cracow, Poland.
Citation
Vancouver
Suchy W, Buś Z, Król M, Dykas K. Adverse Reactions to Fluoroquinolones – Focus on Tendinopathy, QT Prolongation, and Neuropathy: A Review. Int J Pharm Phytopharmacol Res. 2024;14(1):23-35. https://doi.org/10.51847/HHoSB9BTtW
APA
Suchy, W., Buś, Z., Król, M., & Dykas, K. (2024). Adverse Reactions to Fluoroquinolones – Focus on Tendinopathy, QT Prolongation, and Neuropathy: A Review. International Journal of Pharmaceutical And Phytopharmacological Research, 14(1), 23-35. https://doi.org/10.51847/HHoSB9BTtW
Download citation:   EndNote   RIS
Article Link:
Downloads: 143
Views: 466
Abstract

Fluoroquinolones are a widely prescribed class of antibiotics that have proven to be effective in treating a range of bacterial infections. However, the use of these drugs is associated with several adverse reactions that can cause significant harm to patients. This article aims to provide a comprehensive overview of the side effects of fluoroquinolones, with a particular focus on tendinopathy, QT prolongation, and neuropathy. Tendinopathy is a rare fluoroquinolone adverse reaction that can cause tendon rupture and significant disability. Patients who are older, taking steroids, and those who have a history of tendon disorders are more likely to develop this complication. Another serious side effect of fluoroquinolone use is QT prolongation. It has the potential to cause arrhythmias, in some cases fatal, and is more likely to occur in patients with pre-existing heart problems, electrolyte imbalances, and those taking drugs that prolong the QT interval. Finally, neuropathy is a less frequent but potentially debilitating adverse reaction affecting peripheral nerves that can manifest as numbness, tingling, muscle weakness, or even paresis.  Given the potential for significant harm associated with fluoroquinolone use, clinicians must carefully consider the risks and benefits of prescribing these drugs, particularly in high-risk populations. Patients receiving them should be closely monitored for any signs and symptoms of these serious adverse reactions to allow for early intervention and appropriate management.

Related articles:
A Review on Bi-layer Tablets
Issue 4 Vol 2, 2013 | M. Namrata
A Review on Liquid Solid Compacts
Issue 2 Vol 2, 2012 | V. N. L. Sirisha
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Issue 1 Vol 11, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Issue 1 Vol 9, 2019 | Sreevidya V.S
Volume 15
Issue 1
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2024 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.